Caccialanza R., Palladini G., Klersy C., et al., Malnutrition at Diagnosis Predicts Mortality in Patients With Systemic Immunoglobulin LightChain Amyloidosis Independently of Cardiac Stage and Response to Treatment, JPEN Journal of Parenteral and Enteral Nutrition 38, no
The LC and ALC levels in the ineffective-treatment group were not significantly increased after treatment (detailed results are shown in Table 3)
Therapeutic impact of vildagliptin vs
A daily dose of 1530 ml works best for most users depending on training intensity
What complications does the article say perimenopause adds to GLP-1 safety screening
Munker R, Younes A, Cabanillas F, Andreeff M